{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-21-100070","form_type":"8-K","ticker":"MED","cik":"0000910329","company_name":"MEDIFAST INC","filed_at":"2021-08-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:21.224737+00:00","generated_at":"2026-06-29T22:58:25.611648+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Medifast Q2 2021 revenue $394.2M (+79% YoY), EPS $3.96; FY guidance $1.425-1.525B","bullets":["Revenue $394.2M, up 79.2% YoY; net income $47M (+114.1%); diluted EPS $3.96 (+112.9%).","Active OPTA VIA coaches 59,200 (+62.2%); revenue per coach $6,662 (+13.9%).","Gross margin 74.5% vs 72.4%; operating income $61.4M, up 118.5%","FY2021 guidance: revenue $1.425-1.525B, EPS $12.70-14.17.","Declared $1.42/sh dividend (pay Aug 6); $12.2M share repurchases; $125M credit facility undrawn."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-21-100070","json":"https://secwatch.observer/filing/0001104659-21-100070.json","markdown":"https://secwatch.observer/filing/0001104659-21-100070.md","text":"https://secwatch.observer/filing/0001104659-21-100070.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/910329/000110465921100070/0001104659-21-100070-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/910329/000110465921100070/tm2124088d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T22:58:25.611648+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}